BVS
Bioventus IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$613.05M
P/E Ratio
27.58
EPS
$0.33
Beta
0.69
52W High
$9.53
52W Low
$5.81
50-Day MA
$8.59
200-Day MA
$7.48
Dividend Yield
—
Profit Margin
4.00%
Forward P/E
11.85
PEG Ratio
1.19
About Bioventus Inc
Bioventus Inc., a medical device company, focuses on developing and commercializing clinical treatments that involve and enhance the body's natural healing process in the United States and internationally. The company is headquartered in Durham, North Carolina.
Fundamentals
| Revenue (TTM) | $568.09M |
| Gross Profit (TTM) | $388.16M |
| EBITDA | $77.64M |
| Operating Margin | 13.80% |
| Return on Equity | 13.20% |
| Return on Assets | 4.99% |
| Revenue/Share (TTM) | $8.53 |
| Book Value | $2.74 |
| Price-to-Book | 3.27 |
| Price-to-Sales (TTM) | 1.08 |
| EV/Revenue | 1.489 |
| EV/EBITDA | 8.52 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 2.80% |
| Shares Outstanding | $67.37M |
| Float | $33.35M |
| % Insiders | 11.80% |
| % Institutions | 77.93% |
Historical Volatility
HV 10-Day
32.03%
HV 20-Day
35.61%
HV 30-Day
45.21%
HV 60-Day
39.42%
HV Rank
48.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.80 target)
1
Strong Buy3
BuyData last updated: 4/10/2026